Search Press releases Keywords From To 1 Aug 2012 UCB half year results 2012: on track for growth Read More 16 Jul 2012 UCB Launches Neupro® in the U.S. to treat Parkinson’s Disease and Restless Legs Syndrome Read More 28 Jun 2012 Acquisition of own shares Read More 25 Jun 2012 UCB wins “Company Of the Year” at the European Mediscience Awards Read More 21 Jun 2012 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More 21 Jun 2012 Observational study in routine clinical practice setting showed that Neupro® (rotigotine transdermal patch) improved day- and night-time symptoms of Restless Legs Syndrome Read More Pagination First page Previous page Previous … Page 122 Page 123 Page 124 Page 125 Current page 126 Page 127 Page 128 Page 129 Page 130 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
